Check out the latest NIA blog post by Marilyn Miller which highlights how to access data generated by the Alzheimer’s Disease Sequencing Project (ADSP) and what new resources are available to researchers. The NIA has also made recent updates to the following pages NIA Alzheimer’s Disease Genetics Portfolio and Alzheimer’s Disease Sequencing Project Consortia. Special […]
by Ulli Hain, NOVA Research Company/Lumina Corps “A cross-disciplinary approach to research is essential to understand the complex heterogeneity of Alzheimer’s and other related dementia (ADRD),” said Dr. Corey McMillan, a Penn Neurodegeneration Genomics Center (PNGC) faculty member and associate professor of Neurology. The PNGC uses an interdisciplinary and collaborative approach to studying the genetics […]
PNGC is pleased to announce the release of the FILER, a functional genomics repository developed by NIAGADS, now published in NAR Genomics and Bioinformatics. Functional genomic and annotation data such as tissue-specific regulatory/enhancer elements, transcription factor binding, chromatin states, and interactions are widely used in systems biology, genetic and genomic studies, e.g., to interpret non-coding […]
The Collaborative for Alzheimer’s Disease Research (CADRE) and the Alzheimer’s Disease Genetics Consortium (ADGC) announced that PNGC’s Alessandra Chesi will present at the next Junior Investigator Seminar Series on October 13th. CADRE/ADGC’s Trans-Institutional Seminar Series highlights up-and-coming junior investigators to help strengthen their professional development, foster growth, and enhance knowledge and skills. Dr. Alessandra Chesi […]
ADSP, the Alzheimer’s Disease Sequencing Project, has emerged as a powerful tool for genetics researchers in their work on genomics data analysis. This summer, NIA awarded six grants to fund projects that form the core of the ADSP Functional Genomics Consortium (FGC). This significant boost will support consortium researchers as they develop free and accessible tools, […]
By Fernanda Ruiz, NOVA Research Company Alzheimer’s Disease (AD) is a devastating disease that affects more than 6 million Americans, a number that is projected to increase considerably in the near future. Scientists looking for the causes of AD use different approaches, including genomic studies like genome-wide association studies (GWAS), that detect associations between genetic […]
By Fernanda Ruiz, NOVA Research Company Alzheimer’s disease (AD) is a degenerative disease that likely is caused by a combination of environmental, lifestyle, and genetic factors, and increasing age. Alzheimer’s Disease Sequencing Project (ADSP) researchers are focused on gaining further insights into the genetic component of this disease, including the role of structural variants (SVs), […]
PNGC is excited to announce that the Genome Center for Alzheimer’s Disease (GCAD) has received a 5-year grant renewal totaling $20 million to continue their work. GCAD, a collaborative research center between Penn, Boston University, Case Western Reserve University, Columbia University, the University of Miami, and the University of Indiana, aims to identify AD-related genes […]
The Collaborative for Alzheimer’s Disease Research (CADRE) and the Alzheimer’s Disease Genetics Consortium (ADGC) are creating a new multi-institutional seminar series to support next generation researchers in Alzheimer’s disease process, diagnosis and care by encouraging collaboration within the AD research community. The new Trans-Institutional Seminar Series will highlight up-and-coming junior investigators to help strengthen their […]
By Kathy Sedgwick, NOVA Research Company Dr. Alessandra Chesi joined the University of Pennsylvania faculty as an Assistant Professor of Pathology and Laboratory Medicine in July 2020. Her work at Penn focuses on the application of transformative technologies as well as functional genomics and systems biology approaches toward gaining insight into the regulation and identity […]
The NIH will host their 2021 Alzheimer’s Research Summit April 19-22. This virtual summit will convene leading AD scientists, innovators, and public health advocates to showcase progress in Alzheimer’s disease research and ideas for supporting the goal of precision medicine for Alzheimer’s treatment and prevention. On Tuesday, April 20, Drs Li-San Wang (Penn) and Timothy […]
Sign up to receive journal club/seminar announcements